Laboratory Centrifuges Market worth $2.2 billion by 2026 - Leading Key Players are Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), Eppendorf AG (Germany)

According to the new market research report "Laboratory Centrifuges Market by Product (Equipment (Microcentrifuge, Ultracentrifuge), Accessories(Tube, Plate)), Model(Benchtop), Rotor Design(Swinging-bucket), Intended Use(Clinical), Application(Diagnostics), End User(Hospitals) - Global Forecast to 2026", published by MarketsandMarkets™, the global market is projected to reach USD 2.2 billion by 2026 from USD 1.8 billion in 2021, at a CAGR of 4.0% from 2021 to 2026.

Browse in-depth TOC on "Laboratory Centrifuges Market"

411 – Tables
50 – Figures
342 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=197749088&utm_source=openpr&utm_medium=referral&utm_campaign=paidpr

The growth of this market is driven by increasing R&D investments and research grants; rising technological advancements and innovative rotor designs; increasing prevalence of infectious diseases leading to a higher volume of sample testing & cell-based research in laboratory centrifuges; and widening applications of laboratory centrifuges.

"Equipment are expected to hold the largest share of the laboratory centrifuges market, by product in 2021."

Based on product, the market is segmented into equipment and accessories. In 2020, the equipment segment accounted for the largest share of the market. The large share of the equipment segment can be attributed to the requirement of the repeated purchase of accessories such as tubes, bottles, and buckets.

"Benchtop centrifuges are expected to hold the largest share of the laboratory centrifuges market, by model type in 2021."

Based on model type, the market is segmented into benchtop and floor-standing centrifuges. Among these, the benchtop centrifuges segment accounted for the larger market share since these centrifuges are cost-effective, versatile, easy to use, smaller in size, and considerably lighter in weight. These advantages have resulted in their increased adoption in the laboratory centrifuge market.

"General purpose centrifuges are expected to hold the largest share of the laboratory centrifuges market, by intended use in 2021."

Based on intended use, the laboratory centrifuges market is segmented into clinical, preclinical, and general purpose centrifuges. The general purpose centrifuges segment accounted for the largest market share in 2020, owing to an increase in cellular research and the diagnosis of blood-related diseases are the major factors driving the growth of this market.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=197749088&utm_source=openpr&utm_medium=referral&utm_campaign=paidpr

"Fixed-angle rotors are expected to hold the largest share of the laboratory centrifuges market, by rotor design in 2021."

Based on rotor design, the laboratory centrifuges market is segmented into swinging-bucket rotors, fixed-angle rotors, vertical rotors, and other rotors based on rotor design. The fixed-angle rotors segment accounted for the largest share in the laboratory centrifuge equipment market in 2020. Factors such as increasing protein research activities and advantages associated with fixed-angle rotors such as fast runtime and excellent resolution are driving the growth of this market.

"Diagnostics segment are expected to hold the largest share of the laboratory centrifuges market, by application in 2021."

Based on application, the market is segmented into diagnostics, microbiology, cellomics, genomics, proteomics, blood component separation, and other applications (biochemical analysis and nanotechnology research). In 2020, the diagnostics segment accounted for the largest share of the market, owing to the rising prevalence of various diseases and the focus on ensuring early disease diagnosis are the major factors driving the growth of the market for this application segment.

"Hospitals are expected to hold the largest share of the laboratory centrifuges market, by end user in 2021."

Based on end user, the laboratory centrifuge market is segmented into hospitals, biotechnology & pharmaceutical companies, and academic & research institutes. The hospitals segment accounted for the largest share in the market in 2020. The increasing prevalence of diseases, coupled with the growing awareness regarding early diagnosis & treatment, increasing demand for blood, availability of novel and technologically advanced centrifuges for blood separation, and growing number of hospitals, especially in emerging countries, are some of the key factors driving the growth of the market for hospitals.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=197749088&utm_source=openpr&utm_medium=referral&utm_campaign=paidpr

"North America commanded the largest share of the laboratory centrifuges market in 2021."

Based on region, the market is segmented into North America, Europe, Asia Pacific, and Rest of the World (RoW). In 2020, North America commanded the largest share of the market. The large share of North America can be attributed to the rising R&D investments by government bodies, increasing emphasis on better management and the treatment of infectious diseases, and rapid growth in the pharmaceutical industry.

The major players operating in this Laboratory Centrifuge Market are Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), and Eppendorf AG (Germany), KUBOTA Corporation (Japan), Sigma Laborzentrifugen GmbH (Germany), NuAire (US), Sartorius AG (Germany), Andreas Hettich GmbH & Co.KG (Germany), HERMLE Labortechnik GmbH (Germany), Cardinal Health (US), Agilent Technologies (US), Centurion Scientific (UK), QIAGEN N.V. (Netherlands), and Bio-Rad Laboratories, Inc. (US).

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

This release was published on openPR.